Aqua/Water/Eau, Glycerin, Methylpropanediol, 1,2-Hexanediol, Propanediol, Isopropyl Isostearate, Synthetic Beeswax, Stearyl Alcohol, Hydrogenated Polyisobutene, Sodium Hyaluronate, Butyrospermum Parkii (Shea) Butter, Carbomer, Arginine, Sorbitan Stearate, Sucrose Stearate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, C14-22 Alcohols, Ammonium Acryloyldimethyltaurate/VP Copolymer, Niacinamide, Hydrogenated Lecithin, Pelargonium Graveolens Flower Oil, C12-20 Alkyl Glucoside, Sodium Polyacryloyldimethyl Taurate, Sucrose, Hydrogenated Polydecene, Trideceth-10, Ferulic Acid, Glucose, Helianthus Annuus (Sunflower) Seed Oil, Ascorbic Acid, Vaccinium Myrtillus Fruit Extract, Curcuma Longa (Turmeric) Root Extract, Saccharum Officinarum (Sugarcane) Extract, Citrus Aurantium Dulcis (Orange) Fruit Extract, Citrus Limon (Lemon) Fruit Extract, Beta Carotene, Phenoxyethanol, Citral, Citronellol, Geraniol, Geranyl Acetate, Linalool, Pinene, Red 17 (CI 26100), Yellow 11 (CI 47000)
Similarly, imatinib alone increased tumor hypoxia in control tumors but no effect on FGF-2 + tumors (Fig
Significant advancements have been achieved in the development of RNA modification therapeutics in recent years
[0065] Embodiment 58: The antibody of embodiment 50, wherein said antibody contains at least one light chain variable region of an M25EG antibody
[PubMed] [Google Scholar] 74.O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., Molliver M.E
